Treatment of Acquired Hemophilia A (AHA) with Rituximab (R): Clinical Outcomes and Cost of Hemostatic Agents

被引：0
|
作者：
Roengvoraphoj, Monic [1 ]
Jensen, Eleanor R. [1 ]
Mckernan, Laurel [1 ]
Briggs, Anna [1 ]
Ornstein, Deborah L. [2 ,3 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
[2] Dartmouth Med Sch, Dept Pathol, Lebanon, NH USA
[3] Dartmouth Med Sch, Dept Med, Lebanon, NH USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1358 / 1358
页数：1
相关论文
共 50 条
  • [21] FEIBHAC study: prospective clinical and biological evaluation of antihemorrhagic treatment with aPPCs (Factor eight inhibitor bypassing activity) in Acquired Hemophilia A (AHA)
    Borg, J-Y
    Negrier, C.
    Durieu, I
    Levesque, H.
    Dolimier, E.
    Villette, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 670 - 671
  • [22] Successful Treatment of Acquired Hemophilia A With Rituximab and Steroids in a 5-Year-Old Girl
    Fletcher, Matthew
    Crombet, Ofelia
    Morales-Arias, Jaime
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (02) : E103 - E104
  • [23] Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan
    Ogawa, Yoshiyuki
    Yanagisawa, Kunio
    Uchiumi, Hideki
    Ishizaki, Takuma
    Mitsui, Takeki
    Gouda, Fumito
    Ieko, Masahiro
    Ichinose, Akitada
    Nojima, Yoshihisa
    Handa, Hiroshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (01) : 82 - 89
  • [24] Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan
    Yoshiyuki Ogawa
    Kunio Yanagisawa
    Hideki Uchiumi
    Takuma Ishizaki
    Takeki Mitsui
    Fumito Gouda
    Masahiro Ieko
    Akitada Ichinose
    Yoshihisa Nojima
    Hiroshi Handa
    International Journal of Hematology, 2017, 106 : 82 - 89
  • [25] EMICIZUMAB TREATMENT IN A PATIENT WITH ACQUIRED HEMOPHILIA A - CLINICAL CASE REPORT
    Rahuoja, K.
    Ross, M.
    Varik, M.
    Pikta, M.
    HAEMOPHILIA, 2023, 29 : 112 - 112
  • [26] Repeated administration of low dose monoclonal antiCD20 antibody rituximab (Rtx) in refractory acquired hemophilia A (AHA): a case report
    Pileckyte, R.
    Gailiute, N.
    Malciute, L.
    Drungiene, A.
    Griskevicius, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 478 - 478
  • [27] Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options
    Shetty, Shrimati
    Bhave, Manali
    Ghosh, Kanjaksha
    AUTOIMMUNITY REVIEWS, 2011, 10 (06) : 311 - 316
  • [28] Acquired hemophilia A in women postpartum: Clinical manifestations, diagnosis, and treatment
    Michiels, JJ
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2000, 6 (02) : 82 - 86
  • [29] ACQUIRED HEMOPHILIA-A - OUR EXPERIENCE ON CLINICAL MANIFESTATIONS AND OUTCOMES OF 9 PATIENTS
    GAMBA, G
    MONTANI, N
    CASTELLI, G
    PALLAVICINI, EB
    MONTANI, AW
    PASTORELLI, R
    THROMBOSIS RESEARCH, 1993, 70 : S34 - S34
  • [30] Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre
    Gamba, G.
    Ghidelli, N.
    Lodo, F.
    Montani, N.
    Ambaglio, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1024 - 1024
12345